Viral Haemorrhagic Fevers (Ebola/Lassa/Marburg) for MRCP Part 1
top of page
Search

Viral Haemorrhagic Fevers (Ebola/Lassa/Marburg) for MRCP Part 1

TL;DR

Viral Hemorrhagic Fevers (Ebola/Lassa/Marburg) are high-yield infectious disease topics in MRCP Part 1 because they combine microbiology, epidemiology, acute medicine and infection control. Candidates should focus on transmission routes, travel history, laboratory abnormalities, isolation precautions and the distinguishing features of Ebola, Lassa fever and Marburg virus disease. The exam commonly tests recognition of imported infection syndromes and early management priorities.


Why Viral Haemorrhagic Fevers Matter in MRCP Part 1

The MRCP examiners favour diseases that:

  • Require recognition from limited information

  • Involve public health implications

  • Have important infection-control consequences

  • Present initially with non-specific symptoms

VHFs fit all of these categories.

The clinical stem often begins with:

  • Fever after travel

  • Healthcare worker exposure

  • Severe diarrhoea or shock

  • Thrombocytopenia

  • Abnormal liver function tests

Candidates who identify the epidemiological clues early usually answer these questions correctly.


The 5 Most Tested Subtopics

1. Transmission and Reservoirs

This is one of the highest-yield exam areas.

Disease

Virus Family

Reservoir

Main Transmission

Ebola

Filoviridae

Fruit bats

Body fluids

Marburg

Filoviridae

Fruit bats

Body fluids

Lassa fever

Arenaviridae

Multimammate rat

Rodent contamination and body fluids

Key revision points

  • Ebola and Marburg spread through direct contact with infected blood or body fluids.

  • Nosocomial transmission is common in outbreaks with poor infection control.

  • Lassa fever frequently results from exposure to rodent urine or faeces.

  • Airborne spread is not the primary transmission route in typical outbreaks.

A common exam trap is assuming all VHFs spread primarily through the air.

2. Clinical Presentation

The early presentation is usually non-specific.

Common symptoms

  • Fever

  • Malaise

  • Myalgia

  • Headache

  • Sore throat

  • Vomiting

  • Diarrhoea

As the disease progresses, severe manifestations may develop:

  • Hypotension

  • Shock

  • Multi-organ failure

  • Coagulopathy

  • Encephalopathy

Important MRCP point

Haemorrhage is less common than many candidates assume. Severe capillary leak and shock are often more clinically important.

3. Distinguishing Features of Ebola, Lassa and Marburg

Ebola virus disease

Typical features include:

  • Severe gastrointestinal fluid loss

  • Shock

  • Conjunctival injection

  • High mortality in severe outbreaks

The West African outbreak significantly increased the exam relevance of Ebola.

Marburg virus disease

Marburg closely resembles Ebola clinically but may be linked to:

  • Cave exposure

  • Mining exposure

  • Bat-infested environments

Questions may mention African cave systems or laboratory workers.

Lassa fever

Distinctive features include:

  • More gradual onset

  • Sensorineural hearing loss

  • Less dramatic haemorrhage

High-yield association

Sensorineural hearing loss is classically associated with Lassa fever and is frequently tested.

4. Laboratory Findings

The following abnormalities are commonly seen:

Laboratory finding

Clinical implication

Thrombocytopenia

Consumptive coagulopathy

Raised AST and ALT

Hepatic injury

Leucopenia

Viral marrow suppression

Prolonged clotting times

Coagulopathy

Elevated creatinine

Renal impairment

High-yield fact

In Ebola infection, AST is often higher than ALT.

5. Management and Infection Control

Immediate priorities

  1. Isolation

  2. Infection-control precautions

  3. Specialist notification

  4. Supportive management

  5. Fluid resuscitation

Supportive care remains central

Patients often require:

  • Intravenous fluids

  • Electrolyte replacement

  • Organ support

  • Haemodynamic monitoring

Specific therapy

  • Ribavirin may be used early in Lassa fever.

  • Monoclonal antibody therapies have emerged for Ebola virus disease.

However, MRCP questions usually focus on supportive care and infection control rather than detailed antiviral regimens.

For more infectious diseases revision, explore the Crack Medicine https://www.crackmedicine.com/lectures


High-Yield Revision Outline

10 Facts You Must Know

  1. Ebola and Marburg are filoviruses.

  2. Lassa fever is an arenavirus.

  3. Fruit bats are the major reservoir for Ebola and Marburg.

  4. Rodents transmit Lassa fever.

  5. Travel history is essential in diagnosis.

  6. Severe bleeding is not universal.

  7. Thrombocytopenia is common.

  8. Shock is a major cause of death.

  9. Lassa fever may cause hearing loss.

  10. Isolation is the first management priority.

Medical student revising Ebola, Lassa fever and Marburg virus disease for MRCP Part 1

Practical Mini-Case

A 34-year-old healthcare volunteer returns from Sierra Leone with fever, vomiting and profound weakness. Examination reveals hypotension and conjunctival injection. Blood tests show thrombocytopenia and elevated transaminases.

What is the most appropriate immediate action?

A. Prescribe oral ribavirinB. Start corticosteroidsC. Arrange urgent CT headD. Immediate isolation and specialist notificationE. Begin anticoagulation


Answer: D. Immediate isolation and specialist notification

Explanation

In suspected viral haemorrhagic fever, infection control is the immediate priority. Isolation and early specialist involvement reduce the risk of nosocomial transmission and facilitate appropriate testing and supportive management.

Practise similar clinical scenarios in the Crack Medicine https://www.crackmedicine.com/mock-tests


Practical Study Checklist

Before exam day, ensure you can:

  • Differentiate Ebola, Marburg and Lassa fever

  • Recall their reservoirs and transmission routes

  • Recognise key laboratory abnormalities

  • Interpret travel history clues

  • Identify the first management step

  • Understand isolation requirements

  • Recall the association between Lassa fever and hearing loss

  • Distinguish bacterial sepsis from VHFs

  • Recognise that haemorrhage may be absent

  • Apply infection-control principles correctly


Common MRCP Pitfalls

  • Assuming every patient has massive haemorrhage

  • Forgetting rodent exposure in Lassa fever

  • Ignoring travel history in febrile illness

  • Confusing airborne with direct-contact transmission

  • Delaying isolation while awaiting confirmation


Related MRCP Revision Topics

VHFs are best revised alongside:

  • Tropical medicine

  • Malaria

  • Sepsis and shock

  • Infection prevention

  • Acute liver injury


FAQs

Does Ebola always cause bleeding?

No. Although haemorrhage is classically associated with Ebola, many patients primarily present with fever, diarrhoea, shock and organ dysfunction.

Which viral haemorrhagic fever causes hearing loss?

Lassa fever is strongly associated with sensorineural hearing loss, making it a favourite MRCP association.

What is the first step in managing suspected viral haemorrhagic fever?

Immediate isolation and infection-control precautions are essential before confirmatory testing.

Are Ebola and Marburg transmitted by air?

Direct contact with infected body fluids is the primary route of transmission. Airborne spread is not the dominant mechanism in routine outbreaks.

Is ribavirin effective for all viral haemorrhagic fevers?

No. Ribavirin may be beneficial in Lassa fever but is not standard treatment for Ebola or Marburg virus disease.


Ready to start?

Strengthen your preparation with structured revision via the MRCP Part 1 overview. Practise actively using the Free MRCP MCQs and simulate exam conditions with a Start a mock test.

For deeper understanding, combine this guide with lecture-based revision at:https://www.crackmedicine.com/lectures/


Sources

  1. MRCP(UK) syllabus


    https://www.mrcpuk.org/mrcpuk-examinations/part-1

  2. World Health Organization — Ebola virus disease


    https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease

  3. World Health Organization — Lassa fever


    https://www.who.int/news-room/fact-sheets/detail/lassa-fever

  4. Centers for Disease Control and Prevention — Marburg Virus Disease


    https://www.cdc.gov/marburg/about/index.html

  5. UK Health Security Agency — Management of viral haemorrhagic fever incidents


    https://www.gov.uk/guidance/viral-haemorrhagic-fever-algorithm-and-guidance-on-management-of-patients

  6. Davidson’s Principles and Practice of Medicine, 24th Edition


 
 
 
bottom of page